ORIC Pharmaceuticals Inc (ORIC)
9.33
-0.15
(-1.58%)
USD |
NASDAQ |
Nov 05, 14:32
ORIC Pharmaceuticals Shareholders Equity (Quarterly): 302.40M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 302.40M |
| March 31, 2024 | 328.64M |
| December 31, 2023 | 224.09M |
| September 30, 2023 | 247.41M |
| June 30, 2023 | 268.80M |
| March 31, 2023 | 202.81M |
| December 31, 2022 | 222.35M |
| September 30, 2022 | 214.82M |
| June 30, 2022 | 236.87M |
| March 31, 2022 | 253.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 272.98M |
| September 30, 2021 | 291.54M |
| June 30, 2021 | 258.32M |
| March 31, 2021 | 276.08M |
| December 31, 2020 | 289.78M |
| September 30, 2020 | 184.38M |
| June 30, 2020 | 195.25M |
| March 31, 2020 | -98.42M |
| December 31, 2019 | -90.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-98.42M
Minimum
Mar 2020
328.64M
Maximum
Mar 2024
214.79M
Average
247.41M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 328.91M |
| Total Liabilities (Quarterly) | 26.51M |